acute peripheral arterial

Related by string. * ACUTE . Acute : Severe Acute Respiratory Syndrome . severe acute respiratory . acute renal failure . acute myocardial infarction AMI / peripherals . PERIPHERAL . Peripherals : peripheral nerve . peripheral vascular disease . peripheral vision / arterials . ARTERIAL . Arterial : treat pulmonary arterial . pulmonary arterial hypertension PAH . pulmonary arterial hypertension * *

Related by context. Frequent words. (Click for all words.) 73 Alfimeprase 72 central retinal vein 72 Microplasmin 71 Meets Primary Endpoint 71 Pivotal Trial 70 Pivotal Phase III 69 Pivotal Phase 69 Initiates Phase II 68 Pivotal Study 68 Completes Enrollment 67 Factor VIIa 67 Receives Orphan Drug Designation 67 Initiate Phase 66 Phase III Clinical Trial 66 Eculizumab 66 II Clinical Trial 66 Acute Ischemic Stroke 66 Intracranial 66 Phase III Trial 66 arterial thrombosis 66 Patient Enrollment 66 phenylketonuria PKU developed 66 Daclizumab 65 Bone Graft 65 Diabetic Neuropathy 65 Thiarabine 65 Panzem R 65 Clinical Trial Results 65 phase IIb clinical 65 Lubiprostone 65 Golimumab 65 Commences Phase 65 J Am Coll 65 Ischemic 65 tumor lysis syndrome 64 post operative ileus 64 Drug Candidate 64 Aliskiren 64 TELINTRA 64 Metastatic Melanoma 64 Fidaxomicin 64 QLT# 64 MKC# 64 Recombinant Human 64 Proxinium TM 64 Pegasys ® 64 Fibrillex TM 64 pseudobulbar affect PBA 64 Kuvan R 64 Entereg R 64 Vandetanib 63 6R BH4 63 metastatic castration resistant 63 subcutaneous formulation 63 intra arterial 63 AEG# 63 phenylalanine ammonia lyase 63 heparin induced thrombocytopenia 63 refractory chronic lymphocytic 63 R sorafenib tablets 63 Patients Undergoing 63 gastrointestinal stromal tumors GIST 63 Overactive Bladder 63 liposomal formulation 63 rNAPc2 63 Epidermal Growth Factor Receptor 63 multi kinase inhibitor 63 Diabetic Macular Edema 63 Preclinical Data 63 direct thrombin inhibitor 63 Presents Positive 63 Denufosol 63 J Am Acad 63 rFVIIa 63 phenylketonuria PKU 63 Metastatic Colorectal Cancer 63 immuno inflammatory diseases 63 PEGylated 62 Advancing Drugs 62 Acute Myocardial Infarction 62 Tacrolimus 62 Single Dose 62 relapsing multiple sclerosis 62 Dasatinib 62 Occlusion 62 Ofatumumab 62 AzaSite Plus 62 Cardiac Resynchronization Therapy 62 Lactic acidosis 62 oropharyngeal candidiasis 62 inhaled formulation 62 castrate resistant prostate cancer 62 FDA Accepts 62 diabetic macular edema DME 62 TTR amyloidosis 62 Carotid 62 mTOR inhibitor 62 nosocomial pneumonia 62 ThermoDox R 62 NEBIDO R 62 amikacin

Back to home page